Administering high doses of vitamin D to tuberculosis patients along with standard treatment with antibiotics contributes to accelerate the recovery of these patients, as has been demonstrated in a study carried out by researchers at the University of London, in the United Kingdom. .
The study, which has published 'PNAS', is the first to analyze the effect that vitamin D has on the response of the immune system of patients who are in treatment for suffering an infectious disease. Scientists have noted that high-dose vitamin D may decrease the body's inflammatory response to infection, so patients recover more quickly and their lungs suffer less damage.
High doses of vitamin D can decrease the inflammatory response of the body to infection, so patients recover more quickly and their lungs suffer less damage
The study involved 95 patients with tuberculosis who were divided into two groups, one of which was given high doses of vitamin D along with antibiotic treatment. After eight weeks, the scientists obtained blood samples from both groups and measured the markers of inflammation, proving that they had been reduced in the case of patients who had taken vitamin D. In addition, they also observed that the bacteria that caused the tuberculosis - mycobacterium tuberculosis - disappeared more rapidly from the phlegm of these patients.
The director of the research, Dr. Adrian Martineau, who is a professor of Respiratory Infection and Immunity at the Blizard Institute of the University of London, explains that vitamin D has the ability to reduce this inflammatory response without interacting with antibiotics, and that This increases the possibility that these vitamin supplements may be beneficial for patients undergoing antibiotic treatment against other respiratory infections such as pneumonia.
The expert, however, warns that new studies are needed, involving a larger number of patients, to confirm their conclusions and, in case of obtaining positive results, to recommend the administration of vitamin D in large doses along with the usual drugs in the treatment of tuberculosis and other similar infectious diseases.